Dirk Huebner

Chief Tech/Sci/R&D Officer presso APTEVO THERAPEUTICS INC.

61 anni

Health Technology

Commercial Services

Consumer Services

Profilo

Dirk Huebner is currently the Chief Medical Officer at Aptevo Therapeutics, Inc. He previously worked as the Executive Medical Director at Millennium Pharmaceuticals, Inc. from 2011 to 2017, as the Vice President at Boston Biomedical, Inc. from 2017 to 2018, and as the Chief Medical Officer at Mersana Therapeutics, Inc. from 2018 to 2020.
He holds a doctorate degree from Freie Universität Berlin.

Posizioni attive di Dirk Huebner

Società	Posizione	Inizio
APTEVO THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	-

Tutte le posizioni attive di Dirk Huebner

Precedenti posizioni note di Dirk Huebner

Società	Posizione	Fine
MERSANA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	30/11/2020
Boston Biomedical, Inc. Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million.	Corporate Officer/Principal	01/11/2018
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	01/08/2017

Vedi nel dettaglio l'esperienza di Dirk Huebner

Formazione di Dirk Huebner

Freie Universität Berlin

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Dirk Huebner

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
MERSANA THERAPEUTICS, INC.	Health Technology
APTEVO THERAPEUTICS INC.	Health Technology

Aziende private	2
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.	Health Technology
Boston Biomedical, Inc. Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million.	Commercial Services